anmelden
BX Swiss TOP 30 CHF
1.453,02
PKT
+6,87
PKT
+0,48
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 25.10.05 | Nestlé accumulate | Jyske Bank | |
| 20.10.05 | Roche buy | Merrill Lynch | |
| 20.10.05 | Novartis buy | Merrill Lynch | |
| 20.10.05 | Nestlé hold | SEB | |
| 20.10.05 | Roche equal-weight | Lehman Brothers | |
| 20.10.05 | Holcim kaufen | Helaba Trust | |
| 20.10.05 | Nestlé reduce | SEB | |
| 21.10.05 | Roche neutral-weight | Prudential Financial | |
| 25.10.05 | Roche halten | Helaba Trust | |
| 19.10.05 | UBS buy | SEB | |
| 19.10.05 | Novartis outperform | Goldman Sachs | |
| 21.10.05 | Roche buy | Jyske Bank | |
| 19.10.05 | Novartis overweight | Lehman Brothers | |
| 19.10.05 | Nestlé kaufen | Helaba Trust | |
| 19.10.05 | Roche reduzieren | Independent Research | |
| 20.10.05 | Novartis kaufen | Hamburger Sparkasse | |
| 19.10.05 | Novartis Outperform | Goldman Sachs | |
| 20.10.05 | Roche neutral-weight | Prudential Financial | |
| 18.10.05 | Novartis neutral | Banc of America Sec. | |
| 19.10.05 | Novartis kaufen | Helaba Trust | |
| 21.10.05 | Novartis buy | Jyske Bank | |
| 18.10.05 | Novartis buy | Merrill Lynch | |
| 18.10.05 | Novartis buy | SEB | |
| 18.10.05 | Novartis Neutral | Banc of America Sec. | |
| 21.10.05 | Novartis halten | National-Bank AG | |
| 19.10.05 | Novartis market perform | Piper Jaffray | |
| 19.10.05 | Novartis overweight | Prudential Financial | |
| 17.10.05 | Novartis kaufen | Helaba Trust | |
| 17.10.05 | Nestlé overweight | JP Morgan | |
| 14.10.05 | ABB (Asea Brown Boveri) halten | Helaba Trust | |
| 14.10.05 | Swiss Life Marketperformer | LB Rheinland-Pfalz | |
| 18.10.05 | Roche buy | Jyske Bank | |
| 18.10.05 | Novartis buy | Jyske Bank | |
| 14.10.05 | Swiss Life neutral | WestLB | |
| 13.10.05 | Swiss Life | Der Aktionär | |
| 12.10.05 | Holcim kaufen | Helaba Trust | |
| 12.10.05 | Roche reduzieren | Independent Research | |
| 11.10.05 | Novartis Neutral | Oppenheimer | |
| 13.10.05 | Nestlé overweight | Prudential Financial | |
| 10.10.05 | Swiss Life buy | SRC Research |